Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1

By Burns J.M.   Flaherty P.R.   Romero M.M.   Weidanz W.P.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 1843-1852

Elsevier

Access to resources Recommend Favorite

Gene gun-based co-immunization of merozoite surface protein-1 cDNA with IL-12 expression plasmid confers protection against lethal Plasmodium yoelii in A/J mice

By Sakai T.   Hisaeda H.   Nakano Y.   Zhang M.   Takashima M.   Ishii K.   Maekawa Y.   Matsumoto S.   Nitta Y.   Miyazaki J.-i.   Yamamoto S.   Himeno K.  

Vaccine, Vol. 21, Iss. 13, 2003-03 ,pp. : 1432-1444

Elsevier

Access to resources Recommend Favorite

Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1 19 ) and T helper epitopes of tetanus toxoid

By Keitel W.A.   Kester K.E.   Atmar R.L.   White A.C.   Bond N.H.   Holland C.A.   Krzych U.   Palmer D.R.   Egan A.   Diggs C.   Ballou W.R.   Hall B.F.   Kaslow D.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 531-539

Elsevier

Access to resources Recommend Favorite

Single-chain antibodies produced by phage display against the C-terminal 19 kDa region of merozoite surface protein-1 of Plasmodium yoelii reduce parasite growth following challenge

By Vukovic P.   Chen K.   Qin Liu X.   Foley M.   Boyd A.   Kaslow D.   Good M.F.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2826-2835

Elsevier

Access to resources Recommend Favorite

Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii

By Kedzierski L.   Black C.G.   Stowers A.W.   Goschnick M.W.   Kaslow D.C.   Coppel R.L.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4661-4668

Elsevier

Access to resources Recommend Favorite